FSHD myotubes with different phenotypes exhibit distinct proteomes.

FSHD myotubes with different phenotypes exhibit distinct proteomes.

Facioscapulohumeral muscular dystrophy (FSHD) is a progressive muscle disorder linked to a contraction of the D4Z4 repeat array in the 4q35 subtelomeric region. This deletion induces epigenetic modifications that affect the expression of several genes located in the vicinity. In each D4Z4 element, w...

Full description

Bibliographic Details
Main Authors:	Alexandra Tassin, Baptiste Leroy, Dalila Laoudj-Chenivesse, Armelle Wauters, Céline Vanderplanck, Marie-Catherine Le Bihan, Frédérique Coppée, Ruddy Wattiez, Alexandra Belayew
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3525578?pdf=render

Similar Items

The FSHD atrophic myotube phenotype is caused by DUX4 expression.
by: Céline Vanderplanck, et al.
Published: (2011-01-01)

Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD)
by: Eugénie Ansseau, et al.
Published: (2017-03-01)

Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei
by: Céline Vanderplanck, et al.
Published: (2018-01-01)

DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation.
by: Eugénie Ansseau, et al.
Published: (2009-10-01)

Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation.
by: Eugénie Ansseau, et al.
Published: (2016-01-01)

Single-nucleus RNA-seq identifies divergent populations of FSHD2 myotube nuclei.
by: Shan Jiang, et al.
Published: (2020-05-01)

Designed U7 snRNAs inhibit DUX4 expression and improve FSHD-associated outcomes in DUX4 overexpressing cells and FSHD patient myotubes
by: Afrooz Rashnonejad, et al.
Published: (2021-03-01)

Does DNA Methylation Matter in FSHD?
by: Valentina Salsi, et al.
Published: (2020-02-01)

Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns.
by: Stefania Cheli, et al.
Published: (2011-01-01)

Genotype-phenotype correlations in FSHD
by: Nikolay Zernov, et al.
Published: (2019-03-01)

Internalization of the Extracellular Full-Length Tau Inside Neuro2A and Cortical Cells Is Enhanced by Phosphorylation
by: Mathilde Wauters, et al.
Published: (2016-08-01)

Global Proteomic Analysis Reveals High Light Intensity Adaptation Strategies and Polyhydroxyalkanoate Production in Rhodospirillum rubrum Cultivated With Acetate as Carbon Source
by: Guillaume Bayon-Vicente, et al.
Published: (2020-03-01)

Precise Epigenetic Analysis Using Targeted Bisulfite Genomic Sequencing Distinguishes FSHD1, FSHD2, and Healthy Subjects
by: Taylor Gould, et al.
Published: (2021-08-01)

Structural Proteomics of Herpesviruses
by: Baptiste Leroy, et al.
Published: (2016-02-01)

Therapeutic Strategies Targeting DUX4 in FSHD
by: Laura Le Gall, et al.
Published: (2020-09-01)

Gene expression during normal and FSHD myogenesis
by: Sowden Janet, et al.
Published: (2011-09-01)

Cardiac Involvement in Facioscapulohumeral Muscular Dystrophy (FSHD)
by: Allison Ducharme-Smith, et al.
Published: (2021-05-01)

miRNA expression in control and FSHD fetal human muscle biopsies.
by: Débora Morueco Portilho, et al.
Published: (2015-01-01)

Meeting report: the 2020 FSHD International Research Congress
by: Michael Kyba, et al.
Published: (2020-12-01)

Functional domains of the FSHD-associated DUX4 protein
by: Hiroaki Mitsuhashi, et al.
Published: (2018-04-01)

Induction of a local muscular dystrophy using electroporation in vivo: an easy tool for screening therapeutics
by: Aline Derenne, et al.
Published: (2020-07-01)

Culture Conditions Affect Expression of DUX4 in FSHD Myoblasts
by: Sachchida Nand Pandey, et al.
Published: (2015-05-01)

Are Antioxidants a Potential Therapy for FSHD? A Review of the Literature
by: Adam Philip Denny, et al.
Published: (2017-01-01)

Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (<it>FRG1</it>) expression during human myogenic differentiation
by: Marozzi Anna, et al.
Published: (2009-07-01)

Aberrant splicing in transgenes containing introns, exons, and V5 epitopes: lessons from developing an FSHD mouse model expressing a D4Z4 repeat with flanking genomic sequences.
by: Eugénie Ansseau, et al.
Published: (2015-01-01)

Genetic heterogeneity in South African facioscapulohumeral muscular dystrophy (FSHD) families
by: Van der Merwe, Annelize
Published: (2013)

The cellularisation of mammalian myotubes by myoseverin
by: Duckmanton, Amy
Published: (2004)

Culturing C2C12 myotubes on micromolded gelatin hydrogels accelerates myotube maturation
by: Lance T. Denes, et al.
Published: (2019-06-01)

Ammonia Induces a Myostatin-Mediated Atrophy in Mammalian Myotubes, but Induces Hypertrophy in Avian Myotubes
by: Rachel A. Stern, et al.
Published: (2019-12-01)

Morphologische Untersuchungen an Myoblasten von Patienten, die an facioscapulohumeraler Muskeldystrophie (FSHD) leiden
by: Kißner [geb. Stenger], Stefanie Martina
Published: (2018)

Gene Editing Targeting the DUX4 Polyadenylation Signal: A Therapy for FSHD?
by: Romains Joubert, et al.
Published: (2021-12-01)

DUX4 binding to retroelements creates promoters that are active in FSHD muscle and testis.
by: Janet M Young, et al.
Published: (2013-11-01)

Next-generation sequencing analysis of miRNA expression in control and FSHD myogenesis.
by: Veronica Colangelo, et al.
Published: (2014-01-01)

Muscle Fiber Conduction Velocity Correlates With the Age at Onset in Mild FSHD Cases
by: Matteo Beretta-Piccoli, et al.
Published: (2021-06-01)

A review of Genetic Etiology and Emerging Molecular Therapies for FSHD in Preclinical Studies
by: Mohammad Reza Seyyed taghia, et al.
Published: (2021-03-01)

The Mechanical Stimulation of Myotubes Counteracts the Effects of Tumor-Derived Factors Through the Modulation of the Activin/Follistatin Ratio
by: Alexandra Baccam, et al.
Published: (2019-04-01)

Expression patterns of FSHD-causing DUX4 and myogenic transcription factors PAX3 and PAX7 are spatially distinct in differentiating human stem cell cultures
by: Premi Haynes, et al.
Published: (2017-06-01)

How does pollen chemistry impact development and feeding behaviour of polylectic bees?
by: Maryse Vanderplanck, et al.
Published: (2014-01-01)

BST204 Protects Dexamethasone-Induced Myotube Atrophy through the Upregulation of Myotube Formation and Mitochondrial Function
by: Ryuni Kim, et al.
Published: (2021-03-01)

Hypoxia and Hypoxia-Inducible Factor Signaling in Muscular Dystrophies: Cause and Consequences
by: Thuy-Hang Nguyen, et al.
Published: (2021-07-01)